APPLICATION
ANDA206807
TYPE
ANDA
ORIGINAL APPROVAL
2016-12-13
LATEST ACTION
2022-09-09
ROUTE
ORAL, ORAL-28
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
NORETHINDRONEPrescription
NORETHINDRONE 0.35MG · TABLET · ORAL-28
Approval history
2022-09-09Labeling · Supplement 3 · standardAP
2016-12-13UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.